Amer Al‐Mazrou

PD-L1 is overexpressed on breast cancer stem cells through notch3/mTOR axis

Fatmah A. Mansour, Amer Al‐Mazrou, Falah Almohanna et al. · OncoImmunology · 2020 · 122 citations · Full text

Medicine, Cell Biology, Oncology +16

Profiling of normal and malignant breast tissue show CD44high/CD24lowphenotype as a predominant stem/progenitor marker when used in combination with Ep-CAM/CD49f markers

Hazem Ghebeh, Ghida Majed Sleiman, Pulicat Manogaran et al. · BMC Cancer · 2013 · 104 citations · Full text

Medicine, Cancer Biology, Cell Biology +16

Eugenol potentiates cisplatin anti‐cancer activity through inhibition of ALDH‐positive breast cancer stem cells and the NF‐κB signaling pathway

Syed S. Islam, Ibtehaj S Al-Sharif, Ahlam Sultan et al. · Molecular Carcinogenesis · 2017 · 89 citations

Medicine, Oncology, Pharmacology +13

Differential marker expression by cultures rich in mesenchymal stem cells

Andrew Roberts Wetzig, Ayodele Alaiya, Monther Al‐Alwan et al. · BMC Cell Biology · 2013 · 54 citations · Full text

Life Sciences, Cell Biology, Cell Differentiation +12

PAC exhibits potent anti‐colon cancer properties through targeting cyclin D1 and suppressing epithelial‐to‐mesenchymal transition

Abeer J. Al-Qasem, Huda A. Al‐Howail, Mashael Al‐Swailem et al. · Molecular Carcinogenesis · 2015 · 26 citations

Medicine, Oncology, Pharmacology +17